Featured
What’s Going On With Alibaba Stock Wednesday?

Alibaba Group Holding Limited (NYSE:BABA) is rolling out new features and branding changes to strengthen its AI platform and boost user engagement across its apps. New AI Avatar to Unify User Experience Alibaba introduced "Qwen Dimples," a digital assistant designed…

Apr 22, 2026
Featured
BlackBerry And NVIDIA Tie-Up – What’s Going On?

BlackBerry Limited (NYSE:BB) shares traded lower in Monday's premarket trading. The company announced an expanded collaboration with NVIDIA Corporation (NASDAQ:NVDA) and a new automotive software deal with Leapmotor. QNX Expands NVIDIA Collaboration QNX, a division of BlackBerry, will integrate its OS…

Apr 20, 2026
Featured
Rising Memory Costs Trigger Apple, Samsung’s Premium Power Play

Counterpoint Research says rising memory costs are reshaping the Organic Light-Emitting Diode (OLED) industry in 2026, with companies like Apple Inc. (NASDAQ:AAPL) and Samsung Electronics Co. Ltd. (OTC:SSNLF) shifting strategies toward premium devices and new form factors to navigate pressure…

Apr 15, 2026
Featured
Taiwan Semiconductor Revenue Skyrockets On Unstoppable AI Demand

Key contract chipmaker Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE:TSM) delivered stronger-than-expected first-quarter revenue, with analysts pointing to sustained AI demand and favorable industry trends despite geopolitical and cost pressures. The stock gained in the premarket on Friday after the results.…

Apr 10, 2026
Featured
Why Is Sony Group Stock Gaining Today?

Sony Group Corporation (NYSE:SONY) shares moved higher in Wednesday's premarket session after a major restructuring update. The company is reportedly reshaping its entertainment arm while cutting roles across several divisions to support long-term growth priorities. The layoffs affect Sony Pictures…

Apr 08, 2026
Featured
Why Is Rocket Pharma Stock Soaring Friday?

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) shares are up during Friday’s premarket session following the FDA’s accelerated approval of Kresladi (marnetegragene autotemcel), the first gene therapy for children with severe leukocyte adhesion deficiency-I (LAD-I). FDA Accelerated Approval Drives Investor Sentiment This significant…

Mar 27, 2026